Eszopiclone is a nonbenzodiazepine active pharmaceutical ingredient used in medications for the short-term and long-term management of insomnia. It is one of the few FDA-regulated hypnotic compounds without prescribed limits on treatment duration, with evidence supporting benefits for up to six months and potential efficacy beyond one year.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 138729-47-2
Sodium 5-Difluoromethoxy-2(((3,4-dimethoxy-2-Pyridinyl)-methyl)-sulfinyl)-1H benzimidazole
active pharmaceutical ingredient
Ibandronate sodium anhydrous
active pharmaceutical ingredient
Brinzolamide
active pharmaceutical ingredient
3-((1R,2R)-2-((Dimethylamino)methyl)-1-hydroxycyclohexyl)phenyl beta-D-glucopyranosiduronic acid
O-desmethyltramadol glucuronide impurity
(+/-)-Zopiclone-d3 (N-methyl-d3)
deuterated research standard
Zopiclone
sedative-hypnotic active pharmaceutical ingredient
[(7S)-6-(5-chloro-2-pyridinyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate
GBBSUAFBMRNDJC-INIZCTEOSA-N
CN1CCN(CC1)C(=O)O[C@H]2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl